Suppliers / ZhejiangEastAsiaPharmaceuticalCo., Ltd

ZhejiangEastAsiaPharmaceuticalCo., Ltd

China Updated 9 July 2026

ZhejiangEastAsiaPharmaceuticalCo., Ltd is an API manufacturer based in China.

0
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
ナジフロキサシン「製造専用」 PMDA (Japan) 2
Epalrestat PMDA (Japan) 1
Ketoconazole PMDA (Japan) 1
Ofloxacin PMDA (Japan) 1
オフロキサシン「コーア」 PMDA (Japan) 1
トリメブチンマレイン酸塩 PMDA (Japan) 1
ドネペジル塩酸塩 PMDA (Japan) 1
レボフロキサシン水和物 PMDA (Japan) 1
レボフロキサシン水和物「三洋ライフ」 PMDA (Japan) 1
Donepezilhydrochloride PMDA (Japan) 1
Show all 13 molecules on file
Epalrestat PMDA (Japan) 1
Lanthanumcarbonateoctahydrate PMDA (Japan) 1
Trimebutinemaleate PMDA (Japan) 1

Also appears on these molecule pages

Questions about ZhejiangEastAsiaPharmaceuticalCo., Ltd

What does ZhejiangEastAsiaPharmaceuticalCo., Ltd make?
13 molecules are on record against ZhejiangEastAsiaPharmaceuticalCo., Ltd, including ナジフロキサシン「製造専用」, Epalrestat, Ketoconazole and Ofloxacin. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Checking ZhejiangEastAsiaPharmaceuticalCo., Ltd?

Ask Fred what the record holds on ZhejiangEastAsiaPharmaceuticalCo., Ltd, including filings and inspection history.

Chat with Fred, your AI analyst
Opens WhatsApp. Free to start.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability